JMP Securities Reaffirms Their Buy Rating on Blueprint Medicines (BPMC)
JMP Securities analyst Reni Benjamin maintained a Buy rating on Blueprint Medicines (BPMC – Research Report) today and set a price target of ...
JMP Securities Reaffirms Their Buy Rating on Kemper (KMPR)
JMP Securities analyst Matthew Carletti reiterated a Buy rating on Kemper (KMPR – Research Report) today and set a price target of $85.00. The ...
JMP Securities holds Snap stock at $16 target, cites strong 4Q24
JMP Securities maintained a bullish stance on Snap Inc (NYSE: NYSE:SNAP), reiterating their Market Outperform rating with a $16.00 price target. The endorsement follows Snap's release of its ...
JMP Securities maintains $40 target on Confluent stock
JMP Securities maintained a bullish stance on Confluent Inc (NASDAQ:CFLT), reiterating a Market Outperform rating and a ...